RUBELLA VIRUS - ANVISA Registration 10287410586

Access comprehensive regulatory information for RUBELLA VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287410586 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Jan 22, 2027.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10287410586
2 Related Devices
Registration Details
ANVISA Registration Number: 10287410586
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

ELECSYS RUBELLA IGG
Risk Class III

Registration Details

10287410586

25351485250200652

30280358000186

Company Information

Germany
PT: ALEMANHA

Dates and Status

Jan 22, 2007

22/01/2027

09/18/2025 19:00:01

ELECSYS RUBELLA IGG
Risk Class III

Registration Details

10287410586

25351485250200652

30280358000186

Company Information

Dates and Status

Jan 22, 2007

22/01/2027

09/18/2025 19:00:01